Literature DB >> 2100172

Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium.

T Jansen1, B Xhonneux, J Mesens, M Borgers.   

Abstract

Beta-cyclodextrins are cyclic molecules with a hydrophilic outer side and a central hydrophobic cavity. Through the inclusion of drug molecules into their cavities, i.e. the formation of inclusion complexes, cyclodextrins are able to modify the physical and chemical properties of these molecules. When used in pharmaceutical formulations, they can improve the aqueous solubility, stability, dissolution rate, bioavailability and/or local tolerance of certain drugs. To make an initial evaluation of the potential use of beta-cyclodextrins as vehicles in ophthalmic eye-drop formulations, we studied the effect of a single and of multiple applications of hydroxypropyl-beta-cyclodextrin (HP-beta-CD) 12.5% and of dimethyl-beta-cyclodextrin (DM-beta-CD) 5 and 12.5% solutions on the corneal epithelium of albino and pigmented rabbits with slit lamp biomicroscopy (SLB) and scanning electron microscopy (SEM). We can conclude from this study that DM-beta-CD at concentrations of 5 and 12.5% is not a suitable vehicle for ophthalmic formulations since it is toxic to the corneal epithelium and that HP-beta-CD at a concentration of 12.5% is well tolerated by the rabbit eye and is not toxic to the corneal epithelium when evaluated by SLB and SEM.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100172

Source DB:  PubMed          Journal:  Lens Eye Toxic Res        ISSN: 1042-6922


  7 in total

Review 1.  Cyclodextrins: their future in drug formulation and delivery.

Authors:  V J Stella; R A Rajewski
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

2.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

3.  Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line.

Authors:  P Saarinen-Savolainen; T Järvinen; K Araki-Sasaki; H Watanabe; A Urtti
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

4.  The Intravitreal Injection of Lanosterol Nanoparticles Rescues Lens Structure Collapse at an Early Stage in Shumiya Cataract Rats.

Authors:  Noriaki Nagai; Yuya Fukuoka; Kanta Sato; Hiroko Otake; Atsushi Taga; Mikako Oka; Noriko Hiramatsu; Naoki Yamamoto
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

5.  A Composite System Based upon Hydroxypropyl Cyclodextrins and Soft Hydrogel Contact Lenses for the Delivery of Therapeutic Doses of Econazole to the Cornea, In Vitro.

Authors:  Anepmete Wong; Melissa Fallon; Vildan Celiksoy; Salvatore Ferla; Carmine Varricchio; David Whitaker; Andrew J Quantock; Charles M Heard
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

6.  In Situ Gel Incorporating Disulfiram Nanoparticles Rescues the Retinal Dysfunction via ATP Collapse in Otsuka Long-Evans Tokushima Fatty Rats.

Authors:  Saori Deguchi; Fumihiko Ogata; Mizuki Yamaguchi; Misa Minami; Hiroko Otake; Kazutaka Kanai; Naohito Kawasaki; Noriaki Nagai
Journal:  Cells       Date:  2020-09-25       Impact factor: 6.600

7.  Instillation of Ophthalmic Formulation Containing Nilvadipine Nanocrystals Attenuates Lens Opacification in Shumiya Cataract Rats.

Authors:  Ryoka Goto; Shigehiro Yamada; Hiroko Otake; Yosuke Nakazawa; Mikako Oka; Naoki Yamamoto; Hiroshi Sasaki; Noriaki Nagai
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.